FDA Approvals - Smith & Nephew and Q-MED Enter Into Strategic Alliance in
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment (FinanzNachrichten)
MEMPHIS, Tenn., and UPPSALA, Sweden, June 28 /PRNewswire-FirstCall/ -- Smith&Nephew ( Nachrichten ) Orthopaedics Trauma&Clinical Therapies and Q-MED AB ( Nachrichten ) today announced that they have formed a strategic alliance to develop and commercialize Q-MED's proprietary technology for the production of stabilized non-animal hyaluronic acid, NASHA (tm) for orthopedic uses.
ADVENTRX Initiates CoFactor Phase III Clinical Trial (FinanzNachrichten)
SAN DIEGO, June 28 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, ( Nachrichten ) Inc. today announced the initiation of its Phase III pivotal clinical trial for CoFactor(R) in metastatic colorectal cancer.
Medicis stock shows fatigue (East Valley Tribune)
Usually high-flying Medicis Pharmaceutical Corp. gave up nearly a third of its share value during the last few weeks.